Axsome Therapeutics Inc.

NASDAQ: AXSM · Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.99
-0.19%
After-hours: Aug 15, 2025, 04:57 PM EDT

Axsome Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-287.22M -239.24M -187.13M -130.4M
Depreciation & Amortization
n/a 6.83M 5.56M 1.16M
Stock-Based Compensation
85.22M 62.62M 37.73M 20.8M
Other Working Capital
33.9M 34.81M 41.19M 679.48K
Other Non-Cash Items
39.69M 53.1M 3.66M -104.61K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
33.9M -28.39M 23.67M 324.79K
Operating Cash Flow
-128.41M -145.08M -116.51M -108.23M
Capital Expenditures
-270K -582K -702.11K -307.55K
Cash Acquisitions
n/a n/a -53M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-270K n/a -53,702.1B -307.55B
Investing Cash Flow
-270K -582K -53.7M -307.55K
Debt Repayment
-990K 85M 45M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
18.05M -12.74M -4.18M 11,129.7B
Financial Cash Flow
57.84M 331.01M 284.58M 11.13M
Net Cash Flow
-70.84M 185.35M 114.37M -97.4M
Free Cash Flow
-128.68M -145.66M -117.21M -108.53M